What regulatory pathways (FDA/EMA) are most appropriate for hybrid nanoplatforms combining antimicrobial, regenerative, and AI-enabled functions
Last reviewed: July 7, 2026 Last updated: July 7, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
This decline is associated with reduced energy, mental fatigue, slower cellular repair, and decreased resilience to stress
DSIP may also stimulate the endogenous antioxidant system, influencing various enzymatic levels
2017 study reported improvements in aged mice that were sustained through the observation period, suggesting that senescent cell clearance produces durable benefits once senescent cells are eliminated, their pro-inflammatory SASP burden is removed, allowing tissue recovery that persists beyond the treatment window
PMID: 37277863 Adv Sci (Weinh) Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency
